| Financial Year |
March 31 2023 |
| Monetary Funds |
4,113,838,291.22 |
| Held-for-trading Financial Assets |
910,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
72,728,695.88 |
| Advances to Suppliers |
11,482,729.14 |
| Other Receivables |
43,322,941.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
12,098,729,024.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
429,162,250.16 |
| Total Current Assets |
17,778,207,833.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,810,638,572.38 |
| Investment Properties |
14,419,124,566.14 |
| Fixed Assetes |
62,062,641.68 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,142,410.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,377,755.64 |
| Deferred Income Tax Assets |
770,881,921.00 |
| Other Non-Current Assets |
139,684,755.97 |
| Sub-Total of Non-Current Assets |
26,923,423,258.03 |
| Total Assets |
44,701,631,091.41 |
| Short-Term Loans |
3,553,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,609,518,333.46 |
| Accounts Received In Advance |
40,974,194.48 |
| Employee Compensation Payable |
9,455,452.35 |
| Taxes Payable |
176,037,272.51 |
| Interest Payable |
10,209,024.95 |
| Dividend Payable |
-- |
| Other payables |
1,766,429,354.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,724,140,957.20 |
| Other Current Liabilities |
853,254,018.77 |
| Sub-Total of Current Liabilities |
11,692,549,113.67 |
| Long-term Loans |
7,726,422,982.25 |
| Bonds Payable |
8,145,099,946.14 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
544,865,274.05 |
| Deferred Income Tax Liabilities |
1,082,689,839.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,567,330,275.35 |
| Total Liabilities |
29,259,879,389.02 |
| Paid-In Capital(Or Share Stock) |
1,548,689,550.00 |
| Capital Surplus |
2,636,497,912.55 |
| Surplus Reserve |
768,313,160.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,960,675,024.51 |
| Minority Stockholder's Interest |
3,581,431,143.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,860,320,558.84 |
| Owner's Equity（Stockholder's Equity） |
15,441,751,702.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
44,701,631,091.41 |
